Join
Live feed
·
INSIDERFilingvia Quantisnow
Xenetic Biosciences Inc. logo

Interim CEO and CFO Parslow James F was granted 100,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
XBIO· Xenetic Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XBIO (Xenetic Biosciences Inc.) and more on Quantisnow.